Dagan E - Search Results

1

BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.

Dagan E, Cohen Y, Mory A, Adir V, Borochowitz Z, Raanani H, Kurolap A, Melikhan-Revzin S, Meirow D, Gershoni-Baruch R. Dagan E, et al. Eur J Hum Genet. 2014 Feb;22(2):277-9. doi: 10.1038/ejhg.2013.281. Epub 2013 Nov 27. Eur J Hum Genet. 2014. PMID: 24281364 Free PMC article.

2

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.

Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R. Dagan E, et al. Eur J Hum Genet. 2002 Nov;10(11):724-8. doi: 10.1038/sj.ejhg.5200880. Eur J Hum Genet. 2002. PMID: 12404104

3

A missense mutation in ALDH1A3 causes isolated microphthalmia/anophthalmia in nine individuals from an inbred Muslim kindred.

Mory A, Ruiz FX, Dagan E, Yakovtseva EA, Kurolap A, Parés X, Farrés J, Gershoni-Baruch R. Mory A, et al. Among authors: dagan e. Eur J Hum Genet. 2014 Mar;22(3):419-22. doi: 10.1038/ejhg.2013.157. Epub 2013 Jul 24. Eur J Hum Genet. 2014. PMID: 23881059 Free PMC article.

4

BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.

Gershoni-Baruch R, Dagan E, Fried G, Kepten I, Robinson E. Gershoni-Baruch R, et al. Among authors: dagan e. Eur J Hum Genet. 1999 Oct-Nov;7(7):833-6. doi: 10.1038/sj.ejhg.5200371. Eur J Hum Genet. 1999. PMID: 10573018

5

Hereditary breast/ovarian cancer--pitfalls in genetic counseling.

Dagan E, Gershoni-Baruch R. Dagan E, et al. Clin Genet. 2001 Oct;60(4):310-3. doi: 10.1034/j.1399-0004.2001.600410.x. Clin Genet. 2001. PMID: 11683778

6

Anticipation in hereditary breast cancer.

Dagan E, Gershoni-Baruch R. Dagan E, et al. Clin Genet. 2002 Aug;62(2):147-50. doi: 10.1034/j.1399-0004.2002.620207.x. Clin Genet. 2002. PMID: 12220452

7

Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.

Dagan E, Gershoni-Baruch R, Kurolap A, Fried G. Dagan E, et al. Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12594. Epub 2016 Oct 10. Eur J Cancer Care (Engl). 2017. PMID: 27726213

8

The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.

Gal I, Gershoni Baruch R, Haber D, Dagan E, Eisenberg-Barzilai S, Zidan J, Friedman E. Gal I, et al. Among authors: dagan e. Fam Cancer. 2004;3(1):11-4. doi: 10.1023/B:FAME.0000026837.32470.b4. Fam Cancer. 2004. PMID: 15131400

9

A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women.

Gal I, Kimmel G, Gershoni-Baruch R, Papa MZ, Dagan E, Shamir R, Friedman E. Gal I, et al. Among authors: dagan e. Eur J Cancer. 2006 May;42(8):1129-34. doi: 10.1016/j.ejca.2005.09.035. Epub 2006 Apr 18. Eur J Cancer. 2006. PMID: 16624550

10

Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel.

Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M, Gershoni-Baruch R, Goldberg H, Kaufman B, Ben-Baruch N, Zidan J, Maray T, Soussan-Gutman L, Friedman E. Laitman Y, et al. Among authors: dagan e. Breast Cancer Res Treat. 2011 Jun;127(2):489-95. doi: 10.1007/s10549-010-1217-0. Epub 2010 Oct 20. Breast Cancer Res Treat. 2011. PMID: 20960228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters